Visual Function and Intraocular Pressure Outcomes Following Surgical Intervention in Pediatric Patients with Inflammatory Glaucoma.

IF 2.6 4区 医学 Q2 OPHTHALMOLOGY
Abhiram R Manda, Xiangyu Ji, Jordan Comstock, Stephen J Kim, Qingxia Chen, Karen Joos, Sapna S Gangaputra
{"title":"Visual Function and Intraocular Pressure Outcomes Following Surgical Intervention in Pediatric Patients with Inflammatory Glaucoma.","authors":"Abhiram R Manda, Xiangyu Ji, Jordan Comstock, Stephen J Kim, Qingxia Chen, Karen Joos, Sapna S Gangaputra","doi":"10.1080/09273948.2025.2508408","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluates the outcomes of pediatric uveitic glaucoma eyes that received surgery compared to non-surgical pediatric uveitis eyes.</p><p><strong>Methods: </strong>A retrospective chart review was performed of patients diagnosed with inflammatory glaucoma before the age of 18 years. Outcomes, including intraocular pressure (IOP), visual acuity (VA), and inflammatory activity were assessed over two years.</p><p><strong>Results: </strong>Thirty-six eyes (18 surgically managed, 18 non-surgical) were included in this study. At baseline the surgical eyes had significantly higher median IOP than the non-surgical pediatric uveitis eyes (31.5 mmHg versus 15.0 mmHg; <i>p</i> < 0.001). Two years later, the median IOP between the surgical eyes and non-surgical eyes was not significantly different (12.0 mmHg versus 13.5 mmHg; <i>p</i> = 0.14). Median visual acuity (VA) was not significantly different between surgically managed eyes (logMAR 0.35 [IQR: 0.10-0.50] and non-surgical eyes 0.10 [IQR: 0.03-0.85]; <i>p</i> = 0.92) at baseline. At two years, the median VA in surgical eyes improved to 0.30 (IQR: 0.12-0.70), while the non-surgical eyes maintained a stable median VA of 0.10 (IQR: 0.00-0.20). The mean number of glaucoma medications in the surgical eyes decreased considerably from 3.2 ± 1.6 medications at baseline to 0.67 ± 1.1 at two years.</p><p><strong>Conclusion: </strong>Our data showcases that glaucoma surgery in patients with well controlled uveitis, can provide significant benefit to patients that are refractory to medical management, by reducing IOP and glaucoma medication burden, with excellent visual outcomes at two years.</p>","PeriodicalId":19406,"journal":{"name":"Ocular Immunology and Inflammation","volume":" ","pages":"1-7"},"PeriodicalIF":2.6000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Immunology and Inflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09273948.2025.2508408","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study evaluates the outcomes of pediatric uveitic glaucoma eyes that received surgery compared to non-surgical pediatric uveitis eyes.

Methods: A retrospective chart review was performed of patients diagnosed with inflammatory glaucoma before the age of 18 years. Outcomes, including intraocular pressure (IOP), visual acuity (VA), and inflammatory activity were assessed over two years.

Results: Thirty-six eyes (18 surgically managed, 18 non-surgical) were included in this study. At baseline the surgical eyes had significantly higher median IOP than the non-surgical pediatric uveitis eyes (31.5 mmHg versus 15.0 mmHg; p < 0.001). Two years later, the median IOP between the surgical eyes and non-surgical eyes was not significantly different (12.0 mmHg versus 13.5 mmHg; p = 0.14). Median visual acuity (VA) was not significantly different between surgically managed eyes (logMAR 0.35 [IQR: 0.10-0.50] and non-surgical eyes 0.10 [IQR: 0.03-0.85]; p = 0.92) at baseline. At two years, the median VA in surgical eyes improved to 0.30 (IQR: 0.12-0.70), while the non-surgical eyes maintained a stable median VA of 0.10 (IQR: 0.00-0.20). The mean number of glaucoma medications in the surgical eyes decreased considerably from 3.2 ± 1.6 medications at baseline to 0.67 ± 1.1 at two years.

Conclusion: Our data showcases that glaucoma surgery in patients with well controlled uveitis, can provide significant benefit to patients that are refractory to medical management, by reducing IOP and glaucoma medication burden, with excellent visual outcomes at two years.

儿童炎症性青光眼手术干预后的视功能和眼压预后。
目的:本研究评价手术治疗儿童葡萄膜性青光眼与非手术治疗儿童葡萄膜炎的疗效。方法:对18岁前诊断为炎症性青光眼的患者进行回顾性分析。结果包括眼内压(IOP)、视力(VA)和炎症活性在两年内进行评估。结果:36只眼(手术18只,非手术18只)纳入本研究。在基线时,手术眼的中位IOP明显高于非手术儿童葡萄膜炎眼(31.5 mmHg vs 15.0 mmHg;p = 0.14)。手术处理眼的中位视力(VA) (logMAR 0.35 [IQR: 0.10-0.50]和非手术处理眼0.10 [IQR: 0.03-0.85])差异无统计学意义;P = 0.92)。两年后,手术眼的中位VA改善到0.30 (IQR: 0.12-0.70),而非手术眼的中位VA保持稳定在0.10 (IQR: 0.00-0.20)。手术眼的平均青光眼药物数量从基线时的3.2±1.6种药物显著减少到两年后的0.67±1.1种药物。结论:我们的数据显示,对控制良好的葡萄膜炎患者进行青光眼手术,可以通过降低IOP和青光眼药物负担,为难以治疗的患者提供显著的益处,并在两年内获得良好的视力结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
15.20%
发文量
285
审稿时长
6-12 weeks
期刊介绍: Ocular Immunology & Inflammation ranks 18 out of 59 in the Ophthalmology Category.Ocular Immunology and Inflammation is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and vision scientists. Published bimonthly, the journal provides an international medium for basic and clinical research reports on the ocular inflammatory response and its control by the immune system. The journal publishes original research papers, case reports, reviews, letters to the editor, meeting abstracts, and invited editorials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信